Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2010 | 03-2009 | 03-2008 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 26,640 | 5,384 | 17,970 |
| Marketable Securities | 27,485 | 25,254 | N/A |
| Other current assets | 8 | 9 | 71 |
| TOTAL | $54,133 | $30,646 | $18,042 |
| Non-Current Assets | |||
| PPE Net | N/A | 6,904 | 9,561 |
| Intangibles | N/A | 718 | N/A |
| TOTAL | $0 | $7,621 | $9,561 |
| Total Assets | $54,133 | $38,268 | $27,602 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 80 | 86 | 145 |
| TOTAL | $80 | $86 | $145 |
| Non-Current Liabilities | |||
| TOTAL | $0 | $0 | $0 |
| Total Liabilities | $80 | $86 | $145 |
| Shareholders' Equity | |||
| Retained earnings | 28,964 | 12,187 | -2,975 |
| Other shareholders' equity | 2,114 | 5,134 | 6,955 |
| TOTAL | $54,053 | $38,182 | $27,458 |
| Total Liabilities And Equity | $54,133 | $38,268 | $27,602 |